The great strength of the PCWG3 is the recognition that second- , third- , and fourth-line treatments offer new possibilities for extending overall survival.
Jonathan Xianglong Meng
Advertisement
Articles by Jonathan Xianglong Meng
Advertisement
Latest Updated Articles
- Oslerian Genomics for Prostate Cancer Oncology
Published: February 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
2
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
3
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
4
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
5
